Abstract
Cancer in women is a very serious public health concern, given that approximately 40% of American women will be diagnosed at some time in their life with a cancer other than a superficial skin cancer and 20% will die from cancer [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Devesa SS. Cancers in women. In: Goldman MB, Hatch MC, editors. Women and health. San Diego: Academic Press, 2000: 863–70.
Wu AH. Epidemiology of lung cancer in women. In: Goldman MB, Hatch MC, editors. Women and Health. San Diego: Academic Press, 2000: 949–61.
Zang EA, Wynder EL. Differences in lung cancer risk between men and women, examination of the evidence. J Natl Cancer Inst 1996;88:183–92.
Baron JA, Newcomb PA, Longnecker MP, et al. Cigarette smoking and breast cancer. Cancer Epidemiol Biomarker Prev 1996;5:399–403.
Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 1999;149:5–12.
Morabia A, Bernstein M, Heritier S, Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 1996;143:918–28.
Brinton LA, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD. Cigarette smoking and the risk of endometrial cancer. Am J Epidemiol 1993;137:281–91.
Parazzini F, La Vecchia C, Negri E, Moroni S, Chatenoud L. Smoking and risk of endometrial cancer: Results from an Italian case-control study. Gynecol Oncol 1995;56: 195–99.
Weiderpass E, Baron JA. Cigarette smoking, alcohol consumption and endometrial cancer risk: A population-based study in Sweden. Cancer Causes Control 2001;12:239–47.
Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998;148:234–40.
Swanson CA, Potischman N, Wilbanks GD, et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993:2:321–27.
Van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514–27.
Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies. J Natl Cancer Inst 1990;82:561–69.
Hunter DJ, Spiegelman D, Adami H-O, et al. Cohort studies of fat intake and the risk of breast cancer—a pooled analysis. N Engl J Med 1996;334:358–61.
Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and risk of breast cancer. J Natl Cancer Inst 1998;90:1724–29.
Davis SR, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in health and disease. Recent Prog Horm Res 1999;54:185–210.
Cramer DW, Harlow BL, Eillett WC, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989;2:66–71.
Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996;5:503–7.
Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994;5:73–82.
Zhang S, Hunter DJ, Hankinson SE, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632–37.
Friedenreich CM. Physical activity and cancer prevention: From observational to intervention research. Cancer Epidemiol Biomarkers Prev 2001;10:287–301.
Peters HP, De Vries WR, Vanberge-Henegouwen GP, Akkarmans LM. Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut 2001;48: 435–39.
Pike MC, Ross RK. Progestins and menopause: Epidemiologic studies of risks of endometrial and breast cancer. Steroids 2000;65:659–64.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713–27.
Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29–43.
Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589–93.
Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–91.
Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92: 328–32.
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–76.
Venn A, Watson L, Lumley J, et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995–1000.
Whittemore AS, Harris R, Itnyre J, the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. Am J Epidemiol 1992;136:1184–1203.
Harlow BL, Cramer DW, Baron JA, Titus-Ernstoff L, Greenberg ER. Psychotropic medication use and risk of epithelial ovarian. Cancer Epidemiol Biomarkers Prev 1998;7: 697–702.
Berkel HJ, Holcombe RF, Middlebrooks M, Kannan K. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev 1996;18:205–17.
Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER. Over-the-counter analgesics and risk of ovarian cancer. Lancet 1998;351:104–7.
Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover Rn. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995;87:1846–52.
Woolf MS, Toniolo PG, Lee EW, et al. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 1993;85:648–52.
Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB. Organochlorine exposure and risk of breast cancer. Lancet 1998;352: 816–20.
Helzlsouer KJ, Alberg AJ, Huang H-Y, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:525–32.
Brownson RC, Alavanja MCR, Chang JC. Occupational risk factors for lung cancer among nonsmoking women, a case-control study in Missouri (United States). Cancer Causes Control 1993;4:449–54.
Wu-Williams AH, Xu ZY, Blot WJ, et al. Occupation and lung cancer risk among women in northern China. Am J Ind Med 1993;24:67–79.
Blair A, Hartge P, Stewart PA, McAdams M, Lubin J. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethlene and other organic solvents and chemicals: Extended follow-up. Occup Environ Med J 1998;55:161–71.
Goldberg MS, Labreche F. Occupational risk factors for female breast cancer: A review. J Occup Environ Med 1996;53:145–56.
Donna A, Crosignani P, Robutti F, et al. Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health 1989;15:47–53.
Streuwing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401–8.
Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494–1501.
Zheng W, Deitz AC, Campbell DR, et al. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:233–39.
Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098–1102.
Huang CS, Chern HD, Chang KJ, Cheng CW, Hus SM, Shen CY. Breast cancer risk associated with genotype polymorphisms of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res 1999;59: 4870–75.
Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res 2001;61:3955–60.
Ballard-Barbash R. Anthropometry and breast cancer. Body size—a moving target. Cancer 1994;74:1090–1100.
Coliditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: Prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995;4:567–71.
Hilakivi-Clarke L, Clarke R, Lippman ME. Perinatal factors increase breast cancer risk. Breast Cancer Res Treat 1994;31:273–84.
Trichopoulos D. Is breast cancer initiated in utero? Epidemiology 1990; 1:95–96.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brinton, L.A. (2002). Environmental Factors Related to Cancers in Postmenopausal Women. In: Lobo, R.A., Crosignani, P.G., Paoletti, R., Bruschi, F. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1061-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1061-1_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5375-1
Online ISBN: 978-1-4615-1061-1
eBook Packages: Springer Book Archive